Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.

MLA

Huisman, Menno V., et al. “Dabigatran Etexilate for Stroke Prevention in Patients with Atrial Fibrillation: Resolving Uncertainties in Routine Practice.” Thrombosis and Haemostasis, vol. 107, no. 5, May 2012, pp. 838–47. EBSCOhost, https://doi.org/10.1160/TH11-10-0718.

APA

Huisman, M. V., Lip, G. Y. H., Diener, H.-C., Brueckmann, M., van Ryn, J., & Clemens, A. (2012). Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice. Thrombosis and Haemostasis, 107(5), 838–847. https://doi.org/10.1160/TH11-10-0718

Chicago

Huisman, Menno V, Gregory Y H Lip, Hans-Christoph Diener, Martina Brueckmann, Joanne van Ryn, and Andreas Clemens. 2012. “Dabigatran Etexilate for Stroke Prevention in Patients with Atrial Fibrillation: Resolving Uncertainties in Routine Practice.” Thrombosis and Haemostasis 107 (5): 838–47. doi:10.1160/TH11-10-0718.